IFNL3, which encodes interferon-l3 (IFN-l3), has received considerable attention in the hepatitis C virus (HCV) field, as many independent genome-wide association studies have identified a strong association between polymorphisms near IFNL3 and clearance of HCV. However, the mechanism underlying this association has remained elusive. In this study, we report the identification of a functional polymorphism (rs4803217) in the 3′ untranslated region (UTR) of IFNL3 mRNA that dictated transcript stability. We found that this polymorphism influenced AU-rich element (ARE)-mediated decay (AMD) of IFNL3 mRNA, as well as the binding of HCV-induced microRNAs during infection. Together these pathways mediated robust repression of the unfavorable IFNL3 polymorphism. Our data reveal a previously unknown mechanism by which HCV attenuates the antiviral response and indicate new potential therapeutic targets for HCV treatment.
Hepatitis C virus (HCV) infects over 150 million people worldwide. Treatment for chronic infection with HCV is based on interferon therapy in combination with ribavirin. A newly approved triplecombination treatment, which includes direct-acting antiviral agents, has improved cure rates to greater than 60% (ref. 1). However, emergence of therapy-resistant HCV variants in patients treated with direct-acting antiviral agents has become an important concern 1,2 . Genome-wide association studies have identified three single-nucleotide polymorphisms (SNPs) near IFNL3 (which encodes interferon-λ3 (IFN-λ3), also known as interleukin 28B (IL-28B)) strongly associated with response of HCV-infected patients to therapy [3] [4] [5] [6] and natural clearance of infection with HCV 6, 7 . However, the functional polymorphism that mediates those associations has remained unknown.
IFN-λ3 is a member of the IFN-λ cytokine family, which is composed of IFN-λ1 (IL-29), IFN-λ2 (IL-28A) and IFN-λ3 (IL-28B), all of which are encoded by genes clustered on human chromosome 19 (refs. 8,9) . The expression of members of the IFN-λ family is induced in both hematopoietic and nonhematopoietic cells by various viruses that infect humans 10 . Unlike IFN-α/β signaling, IFN-λ signaling exhibits cellular specificity, as the receptor for IFN-λ is narrowly distributed on epithelial cells, melanocytes and hepatocytes, which suggests that the IFN-λ family of cytokines evolved to specifically protect the epithelium from viral invasion 11 . These are potent antiviral cytokines able to inhibit HCV replication and, when paired with direct-acting antiviral agents, have shown antiviral activity against HCV comparable to that of IFN-α 12, 13 . IFN-λ and IFN-α induce a similar repertoire of interferon-stimulated genes (ISGs) in human hepatocytes, although treatment with IFN-λ induces a steady increase in expression instead of the rapid peak and decrease seen with IFN-α 12, 14 . Several confounding studies have shown that the unfavorable IFNL3 genotype is associated with higher pre-therapy expression of ISGs during HCV infection 15, 16 . However, correlations between ISG expression and IFNL3 genotype have been shown to differ by cell type 16 , and when treatment response (those who do not respond versus those who do respond) is stratified by IFNL3 genotype, there is no difference in total mean baseline ISG expression 17 . This suggests that IFNL3 genotype and pre-therapy expression of ISGs are independent predictors of interferon responsiveness in patients with chronic HCV infection 17 .
While five studies have found a correlation between IFNL3 genotype and expression of IFNL3 and/or IFN-λ3 3, 4, [18] [19] [20] , whereby higher expression of IFNL3 and/or IFN-λ3 is associated with clearance of HCV, three studies have found no such association 5, 15, 21 . One study demonstrating an association in normal liver has also found that people with the favorable IFNL3 genotype have the highest expression of ISGs 19 . As noted above, that is opposite to what has been found by baseline gene expression analyses of patients with chronic HCV infection, which suggests that chronic infection dysregulates the immune response and makes correlations between IFNL3 genotype and gene expression less straightforward. Furthermore, cytokine-encoding mRNAs are extremely labile in nature, which makes them very difficult to measure in biological samples. As there are substantial data supporting a correlation between IFNL3 genotype and expression of IFNL3 and/or IFN-λ3, we sought to determine whether there is a functional variant that mediates differences in the expression of this cytokine.
Four candidate causal SNPs have been identified that are in linkage disequilibrium with the SNPs identified by genome-wide association studies [22] [23] [24] . None of those candidate SNPs, which are located in the IFNL3 promoter, intron, coding region or 3′ untranslated region (UTR), have been previously shown to functionally affect IFNL3 expression. As the expression of cytokine-encoding genes is under tight post-transcriptional control 25 , we hypothesized that variation in the 3′ UTR of IFNL3 (SNP rs4803217) might alter mRNA turnover and protein expression by interfering with regulatory elements. The rs4803217 variant with the unfavorable thymidine (T) residue rather than guanosine (G) at position 53 in the 3′ UTR is most common among African populations (T = 55%; G = 45%) and least common in Asians (T = 7%; G = 93%; http://browser.1000genomes.org/Homo_ sapiens/Variation/Population?db=core;r=19:39733720-39734720;v=r s4803217;vdb=variation;vf=3692579). A similar frequency is seen for the 'tag' (i.e., marking and nonfunctional) SNP rs12979860 (identified by genome-wide association studies), which is in linkage disequilibrium with the SNP in the 3′ UTR. The high frequency of the unfavorable T polymorphism in African populations has been proposed as the reason for the finding that African patients are less likely to clear HCV than are Asian patients 7 . In this study, we found that the IFNL3 SNP rs4803217 was responsible for robust expression differences between the genotype (G/G) associated with clearance of HCV (the 'clearance genotype') and the genotype (T/T) associated with no clearance of HCV (the 'nonclearance genotype') and thus identified rs4803217 as a critical functional SNP that directed the outcome of HCV infection by controlling the stability of IFNL3 mRNA. Our data revealed that HCV was able to induce two microRNAs (miRNAs), miR-208b and miR-499a-5p, that target the polymorphic region of the IFNL3 3′ UTR. This is a previously unknown strategy by which HCV evades the immune system and suggests these miRNAs could be therapeutic targets for restoring the host antiviral response.
RESULTS

Influence of SNP rs4803217 in the 3′ UTR of IFNL3 mRNA
We evaluated the influence of the 3′ UTR SNP rs4803217 on the posttranscriptional regulation and stability of IFNL3 mRNA. We generated full-length 3′ UTRs of IFNL3 with either T (IFNL3-T) or G (IFNL3-G) at position 53 in the 3′ UTR and cloned those downstream of the gene encoding firefly luciferase, for use as a reporter ( Fig. 1a and Supplementary Fig. 1a,b) , then transfected human hepatoma (HepG2 and Huh7) cells with those constructs and measured luciferase activity. The IFNL3-T 3′ UTR conferred 30-40% lower luciferase activity than did the IFNL3-G 3′ UTR (Fig. 1b) . We next assessed the effect of rs4803217 on mRNA stability. Analysis of the firefly luciferase-encoding mRNA that remained in HepG2 cells after treatment with actinomycin D revealed that mRNA bearing the IFNL3-T 3′ UTR decayed twice as fast as that bearing the IFNL3-G 3′ UTR (Fig. 1c) , which demonstrated that this single nucleotide change affected the general stability of the mRNA transcript. Together these data demonstrated a strong influence of rs4803217 on the stability and expression of IFNL3.
As with many cytokine-encoding genes, the 3′ UTR of IFNL3 contains cis-acting stretches of adenosine-uridine repetitions (AU-rich elements (AREs)), at positions 33-37, 58-62 and 79-83 ( Fig. 1d and Supplementary Fig. 1a ). AREs are perhaps the best-known determinants of mRNA stability, as degradative RNA-binding proteins can bind to AREs, which leads to ARE-mediated decay (AMD) of the transcript 26 . IFNL3 can be categorized as a class I ARE-containing mRNA, as it has three copies of the pentameric motif AUUUA. We generated luciferase reporter constructs containing 3′ UTRs of IFNL3 mRNA with disrupted ARE motifs (∆ARE), in which the original sequence of AUUUA was mutated to AUCUA (Fig. 1d) , and measured luciferase expression in HepG2 cells transfected with those constructs. Both the IFNL3-T(∆ARE) 3′ UTR and the IFNL3-G(∆ARE) 3′ UTR were completely protected from repression and demonstrated equivalent 'rescue' relative to that of the IFNL3-T and IFNL3-G 3′ UTRs (Fig. 1e) . These data demonstrated that the AREs in the IFNL3 3′ UTR were functional and facilitated AMD of this transcript.
The difference between IFNL3-T expression and IFNL3-G expression was not maintained in the absence of AMD ( Fig. 1e) , which suggested that AMD may have had a greater effect on the stability of IFNL3-T. To explore this further, we generated luciferase reporter constructs with individual ARE sites (1-3) disrupted in the IFNL3-T 3′ UTR or IFNL3-G 3′ UTR. We observed that the difference in the regulation of IFNL3-T and IFNL3-G was maintained only in the presence of both ARE 1 and ARE 2 and did not require activity at ARE 3 ( Fig. 1f) . However, when we disrupted ARE 1 or ARE 2 individually, the difference in the degradation of the IFNL3-T 3′ UTR and that of the IFNL3-G 3′ UTR was not significant ( Fig. 1f ). This suggested that ARE 3 participated in equal degradation of both variants, whereas the combined activity of ARE 1 and ARE 2 facilitated different degrees of AMD. It is possible that the location of rs4803217 between ARE 1 and ARE 2 alters the local secondary structure of the mRNA and thereby disrupted the ability of ARE-binding proteins to effectively degrade the IFNL3-T mRNA. Comparison of predicted base-pair probabilities of the IFNL3-T 3′ UTR versus that of the IFNL3-G 3′ UTR showed that the only sites with significant differences were ARE 1, ARE 2 and the SNP rs4803217 ( Supplementary Fig. 1c ). Structural changes in motif-defining sequences, such as AREs, in the 3′ UTR can have functional consequences by influencing accessibility to trans-acting RNA-decay factors 27 .
The cytokines IFN-λ2 and IFN-λ3 have 98% amino acid sequence similarity 8, 9 and 95% sequence identity in the 3′ UTRs of their mRNA ( Supplementary Fig. 1a ). In contrast, the 3′ UTRs of IFNL3 and IFNL1 have a low sequence identity (47%) but do share conservation in the AREs (Supplementary Fig. 2a ). The T variant of rs4803217 in the 3′ UTR of IFNL3 is the ancestral allele, and only in humans has a G variant emerged (Supplementary Fig. 2b) . Notably, there are no known variants of IFNL2 (which encodes IFN-λ2) associated with clearance of HCV. In contrast to type I and type II interferons, members of the IFN-λ family have been strongly affected by positive selection 28 . That analysis revealed that five SNPs near or in IFNL3, including rs4803217, have rapidly increased in frequency. However, position 53 (which aligns with rs4803217 in the 3′ UTR of IFNL3) is 'fixed' with a T nucleotide in the 3′ UTR of IFNL2. To understand why the polymorphism at this site was evolutionary selected for in IFNL3 but not IFNL2, we cloned into luciferase reporter constructs the full-length IFNL2 3′ UTR as well as one in which the native T nucleotide at position 53 was replaced with G ( Supplementary Fig. 2c ). When expressed in HepG2 cells, the luciferase activity of the construct with wild-type IFNL2 3′ UTR (T at position 53) was significantly higher (+15%) than that of the construct with IFNL3-T (Fig. 1g) . The luciferase A r t i c l e s activity of the construct with the IFNL2 3′ UTR with substitution of G for T at position 53 was only slightly greater than that of the construct with the wild-type IFNL2 3′ UTR ( Fig. 1g) . We also investigated whether an IFNL2(∆ARE) 3′ UTR would 'rescue' expression of the luciferase reporter and found that, like the IFNL3(∆ARE) 3′ UTRs, it was completely protected from repression ( Supplementary Fig. 2d ).
Overall these data indicated that, like IFNL3 mRNA, IFNL2 mRNA was subjected to post-transcriptional regulation by AMD but was not degraded to the same extent as was IFNL3-T.
Regulation of IFNL2 and IFNL3 by miRNAs As a 3′ UTR variant of HLA-C is known to be strongly associated with control of infection with human immunodeficiency virus and to drive high expression of HLA-C by escaping regulation by the miRNA miR-148 (ref. 29) , we reasoned such a mechanism could act on IFNL3. miRNAs are a class of small (~22-nucleotide) regulatory RNA molecules whose main function is to decrease the abundance of protein-encoding mRNA by directly pairing with the 3′ UTR of the target mRNA 30 . Published work has demonstrated that miRNAs can act together with ARE-binding proteins to destabilize cytokine-encoding mRNAs 31 . We investigated whether the 3′ UTR SNP rs4803217, in addition to mediating differences in AMD, could influence recruitment of miRNAs to the 3′ UTR of IFNL3. We examined the 3′ UTR sequence around the site of rs4803217 for predicted miRNA-binding sites and identified potential binding sites for hsa-miR-208b and hsa-miR-499a-5p, two miRNAs with identical seed regions in the IFNL3-T 3′ UTR and IFNL2 3′ UTR ( Fig. 2a and Supplementary Fig. 1a ). The SNP rs4803217 with the T-to-G substitution is in the miRNA seed region and would therefore be predicted to prevent the binding of those miRNAs to the IFNL3-G 3′ UTR.
MIR208B (hsa-miR-208b) and MIR499A (hsa-miR-499) are in the introns of MYH7 (which encodes myosin heavy chain 7) and MYH7B (which encodes myosin heavy chain 7B), respectively ( Fig. 2b) . They are part of a group of miRNAs called 'myomiRs' because of their location and coexpression with their corresponding myosin-encoding genes 32 . A key feature of those myomiRs is their restricted expression to cardiac and slow skeletal muscle, as MYH7 and MYH7B encode the major contractile proteins of muscle. In this context, miR-208b and miR-499a-5p control myosin expression and skeletal myofiber phenotypes by targeting transcriptional repressors of myofiber-encoding genes 32 . As those miRNAs are not normally expressed in the liver and we did not detect their constitutive expression in HepG2 or Huh7 cells, we assessed whether infection with HCV could induce their expression. We found that infection with HCV resulted in the induction of MYH7 and MYH7B and their associated myomiRs ( Fig. 2c,d and Supplementary Fig. 3a ). Another member of the myomiR family encoded in the myosin-encoding gene MYH6, miR-208a, has a seed sequence identical to that of miR-208b and miR-499a-5p and was predicted to target the IFNL3-T 3′ UTR, but we did not detect its induction during HCV infection (data not shown). Therefore, in this study, we set out to characterize the effects of the HCV-inducible myomiRs miR-208b and miR-499a-5p on the 3′ UTRs of IFNL2 and IFNL3.
We cotransfected HepG2 cells with miR-208b, miR-499a-5p or negative control mimics and with luciferase reporter constructs containing the IFNL3-T, IFNL3-G or IFNL2 3′ UTR. Both miR-208b and miR-499a-5p significantly reduced the luciferase activity of the IFNL3-T 3′ UTR but not the IFNL3-G 3′ UTR, relative to that of cells transfected with the negative control mimics ( Fig. 2e) . To determine whether ARE-binding proteins are involved in recruitment of the miRNA-induced silencing complex (miRISC) to the IFNL3 3′ UTR, we cotransfected cells with mimics of the myomiRs and the IFNL3(∆ARE) luciferase reporter constructs. Similar to results obtained with the IFNL3-T and IFNL3-G 3′ UTRs, the myomiRs were able to repress the IFNL3-T(∆ARE) 3′ UTR but had no significant effect on the npg IFNL3-G(∆ARE) 3′ UTR (Supplementary Fig. 3b) . Therefore, ARE-binding proteins were not physically required for recruitment of the miRISC to the IFNL3-T 3′ UTR. The luciferase activity of the IFNL2 3′ UTR was also significantly reduced by the mimics of the myomiRs but was more resilient against low concentrations of the mimics than was the luciferase activity of the IFNL3 3′ UTR ( Fig. 2e and Supplementary Fig. 3c ). Overall these results demonstrated that miR-208b and miR-499a-5p directly targeted and mediated degradation of the IFNL3-T 3′ UTR and that the SNP rs4803217 with the T-to-G substitution conferred protection against repression by the myomiRs. We found that the IFNL3 genotype of our HepG2 cell line is T/T at the site of rs4803217, so we used these cells to study possible regulation of endogenous IFNL2 and IFNL3 transcripts by myomiRs. We treated HepG2 cells with the synthetic RNA duplex poly(I:C), which is a ligand of Toll-like receptor 3, and observed peak IFNL mRNA expression around 12 h after stimulation (Supplementary Fig. 3d) . In HepG2 cells transfected with miR-208b, miR-499a-5p or negative control mimics and then stimulated with poly(I:C), both myo-miRs significantly repressed expression of IFNL2 mRNA and IFNL3 mRNA (Fig. 2f) . To assess whether that repression was a result of destabilization of the mRNA, we analyzed the stability of the mRNA in the presence of the mimics of the myomiRs after treatment with actinomycin D. To induce expression of IFNL2 and IFNL3, we stimulated HepG2 cells with the HCV 3′ poly-U/UC tract, a pathogen-associated molecular pattern (PAMP) in the 3′ UTR of HCV that has potent immunostimulatory effects on hepatocytes, such as inducing type I interferons 33 . We found strong induction of the expression of both IFNL2 and IFNL3 in HepG2 cells by the HCV PAMP ( Supplementary  Fig. 3e ). We transfected miR-208b, miR-499a-5p or negative control mimics, as well as the HCV PAMP, into HepG2 cells and arrested new transcription with actinomycin D 16 h after stimulation. We observed that miR-208b and miR-499a-5p each reduced the half-life of IFNL2 and IFNL3 mRNA to nearly half that of cells transfected with negative control mimics (Fig. 2g) .
To support the proposal that these miRNAs directly target endogenous IFNL2 and IFNL3 transcripts, we measured the association of IFNL2 and IFNL3 mRNA with the miRISC. We transfected HepG2 cells for 16 h with either negative control mimics or a 'cocktail' of mimics of miR-208b and miR-499a-5p, along with the HCV PAMP. We then immunoprecipitated Ago2, one of the main miRISC proteins involved in mRNA cleavage, and detected both IFNL2 and IFNL3 mRNA among RNA immunoprecipitated together with Ago2 in cells transfected with negative control mimics (Supplementary Fig. 3f) ; this demonstrated recruitment of the miRISC by some endogenous miRNA(s). However, cells treated with the mimics of miR-208b and miR-499a-5p had a significantly greater abundance of IFNL2 mRNA (P < 0.01) and IFNL3 mRNA (P < 0.001) among RNA immunoprecipitated together with Ago2 than did cells transfected with negative control mimics (Supplementary Fig. 3f ). We also amplified both miR-208b and miR-499a-5p from the Ago2-associated RNA in the cells transfected with mimics of the myomiRs (data not shown). Collectively, these data confirmed that miR-208b and miR-499a-5p directly targeted and destabilized endogenous IFNL2 and IFNL3 transcripts.
HCV-induced myomiRs repress IFNL3-T transcripts
To investigate the effect of endogenous HCV-induced myomiRs on the IFNL3 3′ UTR variants, we developed reporter constructs containing sequence encoding either the red fluorescent protein mCherry or enhanced green fluorescent protein (eGFP) with the 
npg
A r t i c l e s IFNL3-T 3′ UTR or IFNL3-G 3′ UTR, respectively, cloned downstream (Supplementary Fig. 4a ). Those reporter constructs allowed simultaneous expression of the IFNL3 3′ UTR variants in the same cells (Supplementary Fig. 4b ). Flow cytometry of Huh7 cells transfected with those constructs showed a difference in expression of the IFNL3-T 3′ UTR and that of the IFNL3-G 3′ UTR (Fig. 3a) , as we had noted before by luciferase assay (Fig. 1b) . To assess whether the HCV-induced myomiRs repressed the IFNL3 3′ UTR variants differently in the same cells, we used that mCherry-eGFP coexpression system along with specific locked nucleic acid (LNA) inhibitors of the induced myomiRs. We designed the LNA inhibitors to inhibit miR-208b and miR-499a-5p with high specificity and demonstrated their efficiency (>75% at 48 h after transfection) in HepG2 cells stably overexpressing miR-208b or miR-499a-5p (Fig. 3b) . To assess the effect of the inhibitors on HCV-induced myomiRs, we infected Huh7 cells with HCV and then cotransfected them with the mCherry-eGFP IFNL3 3′ UTR reporter constructs and LNA inhibitors of myomiRs or control inhibitors. We also compared the mean fluorescent intensity of those cells with that of uninfected cells with the fluorescent reporters in the presence or absence of mimics of myomiRs. Cells infected with HCV suppressed the IFNL3-T 3′ UTR reporter but not the IFNL3-G 3′ UTR reporter (Fig. 3c) . The level of repression achieved by the HCV-induced myomiRs was similar to that achieved with the mimics (Fig. 3c) . Notably, inhibition of miR-208b and miR-499a-5p in infected cells resulted in a significant increase in the expression of IFNL3-T but not that of IFNL3-G (Fig. 3c) . Therefore, infection with HCV accelerated the degradation of mRNA bearing the IFNL3-T 3′ UTR but not that of mRNA bearing the IFNL3-G 3′ UTR, via the induction of myomiRs. We next assessed the effect of the inhibition of myomiRs on endogenous IFNL3 transcripts during infection. Huh7 cells infected with HCV are weak producers of interferons because HCV disrupts signaling downstream of the helicase RIG-I, an essential pathogenrecognition receptor of HCV [34] [35] [36] [37] . However, IFNL2 mRNA and IFNL3 mRNA were detectable in Huh7 cells at 72 h after infection with HCV at a high multiplicity of infection ( Fig. 3d-f) , so we used those conditions to study the regulation of IFNL2 and IFNL3 mRNA by the myo-miRs during infection. Since the genotype of our Huh7 cell line is T/T at the rs4803217 site, we were able to assess the effect of the inhibitors on virus-induced IFNL3 in the presence of virus-induced myomiRs. Induction of the myosin-encoding genes by HCV was unaffected by the presence of the inhibitors of myomiRs, while the expression of myomiRs was significantly reduced (Fig. 3d,e ). We then measured IFNL2 and IFNL3 and found that the inhibitors of myomiRs 'rescued' the expression of IFNL2 and IFNL3, in contrast to the negative control inhibitor (Fig. 3f) . Furthermore, despite the high multiplicity of infection required for the expression of IFNL2 and IFNL3 in this in vitro infection system, we observed significantly lower viral copy number and titer in cells treated with the inhibitors of myomiRs than in those treated with negative controls (Fig. 3g,h) . These data demonstrated that HCV-induced miR-208b and miR-499a-5p targeted the rs4803217 SNP in the 3′ UTR of IFNL3 and that inhibition of myomiRs was able to 'rescue' that suppression.
Induction of myosin and myomiRs during HCV infection
To investigate how HCV induces MYH7 and MYH7B, we infected Huh7.5 cells, which are deficient in innate immunological signaling by RIG-I, and measured myosin expression. Both MYH7 and MYH7B, as well as their respective myomiRs (miR-208b and miR-499a-5p), were induced to levels similar to those observed during infection of Huh7 cells (Figs. 2c,d and 4a and Supplementary Fig. 5a ). We also assessed expression of the myosin-encoding genes in HepG2 cells stimulated with poly(I:C) or the HCV PAMP but did not observe any induction of expression ( Fig. 4b) . Therefore, the induction of MYH7 and npg MYH7B by HCV occurred independently of HCV PAMP-RIG-I signaling, which indicated that their induction might require viral RNA replication or expression of HCV proteins. To determine whether induction of the myosin-encoding genes was specific to infection with HCV, we also assessed gene expression in Huh7 cells infected with Sendai virus or West Nile virus. Those viruses were unable to induce MYH7B and induced only low MYH7 expression, despite productive infection and induction of IFNB ( Fig. 4c and Supplementary  Fig. 5b) , which indicated that the induction of MYH7 and MYH7B may have been HCV specific.
Myosin and myomiRs in patients with chronic HCV infection
To determine if patients infected with HCV exhibit hepatic expression of the myosin-encoding genes and their associated myomiRs, we evaluated liver RNA recovered from patients chronically infected with HCV. Five of eight patients showed robust expression of MYH7 that was >200-fold higher than the average expression in uninfected control subjects (Fig. 5a ). Those patients also had significantly higher expression of MYH7B than did the control subjects, albeit at a lower level than MYH7 (>10-fold higher in five of eight patients; Fig. 5a ), similar to our observations of in vitro HCV infection. Also similar to the results obtained by in vitro infection, we did not detect elevated MYH6 expression (data not shown), which supported the proposal of a specific pathway of induction for MYH7 and MYH7B.
Patients infected with HCV also had significantly higher hepatic levels of miR-208b than did uninfected control subjects (Fig. 5a) .
Although those patients had elevated MYH7B expression, we did not detect differences between infected patients and uninfected control subjects in mature miR-499a-5p ( Fig. 5a) . To determine whether that observation was caused by an uncoupling of MYH7B expression from miR-499a-5p, we also assessed the presence of primary miR-499a transcripts and found significantly elevated levels of those in patients chronically infected with HCV than in uninfected control subjects (Fig. 5a) . Therefore, our inability to detect mature miR-499a-5p did not seem to be the result of uncoupling from its parental myosinencoding gene and may have reflected a limitation of the quantitative RT-PCR primers in detecting variations in mature miRNA sequence relative to the reference sequence of mature miR-499a-5p (as in the miRBase microRNA database), which present obstacles for detecting mature miRNA in different tissues 38, 39 . However, we did observe a significant correlation between the expression of MYH7 and that of miR-208b, as well as the expression of MYH7B and that of primary miR-499a transcripts, in the patients examined ( Fig. 5b) , which demonstrated that MYH7 mRNA levels were a reliable 'readout' for miR-208b expression. Overall, these observations demonstrated that HCV induced hepatic expression of genes encoding cardiac and skeletal myosin and their associated myomiRs in HCV-infected patients, in support of the proposed mechanism of repression of IFNL2 and IFNL3-T during infection (Supplementary Fig. 6 ).
DISCUSSION
The work presented here has demonstrated a previously undescribed mechanism by which HCV attenuates the hepatic interferon response. These data suggested that targeted inhibition of miR-208b and miR-499a-5p could 'rescue' the abundance of IFN-λ2 and IFN-λ3 to impart control of HCV infection. Inhibition of miR-122, which is required for HCV replication, has shown promising results in clinical trials demonstrating the feasibility of anti-miRNA therapy 40 . npg A r t i c l e s Therefore, inhibition of HCV-induced myomiRs has the potential to become an important part of treating infection with HCV and mitigating the progression to cirrhosis and liver cancer. As miR-208b and miR-499a-5p are encoded in genes encoding cardiac muscle-and skeletal muscle-specific myosin heavy chains, it is notable that a high prevalence of HCV infection has been reported in patients with hypertrophic cardiomyopathy, dilated cardiomyopathy and myocarditis 41 . Furthermore, autoantibodies to cardiac myosin, including the myosin heavy chains, are commonly observed in patients with those cardiac diseases 42, 43 , which suggests that aberrant induction of cardiac myosin in the liver by HCV may indirectly contribute to cardiac pathology. Our comparative analysis of the 3′ UTRs of IFNL2 and IFNL3 revealed that despite the significant difference in luciferase expression for the T and G variants of IFNL3, the same base-pair change in the 3′ UTR of IFNL2 did not result in an increase of similar magnitude. If the presence of the G variant in the 3′ UTR of IFNL3 is the result of genetic selection for increased IFN-λ3 levels during HCV infection, these data may explain why no such variant exists for IFNL2; IFNL2 was expressed at higher levels than the IFNL3-T variant, and a T-to-G substitution at position 53 in the 3′ UTR of IFNL2 resulted in only a small increase in expression. Therefore, such a change in IFNL2 may not confer a host advantage during infection with HCV. Additionally, IFN-λ3 has been shown to have higher ISG-stimulatory activity than does IFN-λ2, which may make an IFNL3 escape variant more evolutionarily advantageous, as it has a greater capacity to establish an antiviral state 13, 44 .
In this study, we have identified a functional IFNL3 variant associated with clearance of HCV. Our results revealed that the SNP rs4803217 with T-to-G substitution in the 3′ UTR of IFNL3 resulted in increased expression of IFNL3 through escape of both AMD and post-transcriptional regulation by HCV-induced miRNAs. By those two mechanisms of post-transcriptional regulation, IFNL3-T suffered significantly more degradation than did IFNL3-G. A frameshift variant upstream of IFNL3 has been described that creates the novel gene IFNL4 (which encodes IFN-λ4) 45 . Expression of IFNL4 is associated with HCV persistence and a poorer response to therapy with interferon plus ribavirin than that of patients with no IFNL4 expression 45 . Therefore, it may be the combined effect of IFNL4 expression and low IFNL3 expression that makes this haplotype so unfavorable for HCV infection and treatment outcome. However, published work has shown that genes encoding the IFN-λ family are in low linkage disequilibrium in all populations, which suggests that independent positive selection events are targeting these genes 28 . Our data have also shown that HCV infection was specifically able to induce miR-NAs that interacted with rs4803217; this may explain why the IFNL3 locus has been found to be associated only with HCV infection and no other viral infection. Additionally, HCV genotypes may vary in their ability to effectively induce the miRNAs, which may explain why the SNPs of IFNL3 identified by genome-wide association studies do not uniformly associate with response to therapy across infection with HCV of all genotypes. Thus, the identification of this causal SNP in the 3′ UTR of IFNL3 provides a potentially important link between host and HCV genetics.
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